Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

ABUS

Arbutus Biopharma Corp

CIK 0001447028 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$5.21
↑ 0.44 (9.22%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: BullishOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Technicals, Options; Risks: Fundamentals

Key stats

Market Cap
$1.03B
P/E Ratio
6.73
EPS
-0.17
Dividend Yield
Not covered
52W Position
88%
Beta
1.23

Valuation multiples

Fwd P/E
10.25
PEG
0.00
P/B
3.98
P/S
5.67
EV/Revenue
5.57
ROE
59.2%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 88%
$3.44$5.45

Latest Financials

2025-12-31 FY
Revenue
$14.08M
Net Income
-$33.50M
Total Assets
$94.62M
Free Cash Flow
-$39.64M

Recent news